financial statements
The full income statement, balance sheet, and cash-flow statement for IDEXX Laboratories Inc. (IDXX), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 4.30B YoY+10.4% | 3.90B YoY+6.5% | 3.66B YoY+8.7% | 3.37B YoY+4.7% | 3.22B YoY+18.8% | |
2.66B YoY+11.8% | 2.38B YoY+8.6% | 2.19B YoY+9.3% | 2.00B YoY+6.1% | 1.89B YoY+20.3% | ||
1.30B YoY+3.9% | 1.25B YoY+14.4% | 1.09B YoY-1.2% | 1.11B | — | ||
| Operating income | 1.36B YoY+20.5% | 1.13B YoY+2.8% | 1.10B YoY+22.1% | 899M YoY-3.6% | 932M YoY+34.2% | |
| Interest expense | 38.9M YoY+24.5% | 31.2M YoY-25.0% | 41.6M YoY+4.3% | 39.9M YoY+33.7% | 29.8M YoY-10.0% | |
| Pre-tax income | 1.32B YoY+19.3% | 1.11B YoY+4.6% | 1.06B YoY+23.4% | 860M YoY-4.7% | 903M YoY+36.4% | |
| Income tax | 265M YoY+19.3% | 222M YoY+2.7% | 216M YoY+19.5% | 181M YoY+14.6% | 158M YoY+97.6% | |
1.06B YoY+19.3% | 888M YoY+5.1% | 845M YoY+24.4% | 679M YoY-8.8% | 745M YoY+28.0% | ||
$13.08 YoY+22.6% | $10.67 YoY+6.1% | $10.06 YoY+25.3% | $8.03 YoY-6.6% | $8.60 YoY+28.2% | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.41B YoY+1.0% | 1.40B YoY-6.4% | 1.50B YoY+35.7% | 1.10B YoY+15.3% | 956M YoY-10.1% | ||
3.35B YoY+1.7% | 3.29B YoY+1.0% | 3.26B YoY+18.7% | 2.75B YoY+12.7% | 2.44B YoY+6.2% | ||
1.15B YoY+7.6% | 1.07B YoY+12.2% | 952M YoY-23.0% | 1.24B YoY+61.8% | 764M YoY+31.0% | ||
1.75B YoY+2.8% | 1.70B YoY-4.4% | 1.78B YoY-17.0% | 2.14B YoY+22.4% | 1.75B YoY+5.1% | ||
1.61B YoY+0.6% | 1.60B YoY+7.5% | 1.48B YoY+143.9% | 609M YoY-11.8% | 690M YoY+9.2% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
1.18B YoY+27.2% | 929M YoY+2.5% | 907M YoY+66.9% | 543M YoY-28.1% | 756M YoY+16.6% | ||
-136M YoY+34.2% | -207M YoY-65.3% | -125M YoY+35.9% | -195M YoY+33.3% | -293M YoY-167.9% | ||
-1.16B YoY-32.7% | -878M YoY-98.7% | -442M YoY-19.2% | -371M YoY+46.8% | -697M YoY-180.7% | ||
| FX effect on cash | 11.2M YoY+217.5% | -9.53M YoY-548.4% | 2.13M YoY+124.7% | -8.61M YoY-85.5% | -4.64M YoY-239.3% | |
| Net change in cash | -108M YoY+34.7% | -166M YoY-148.5% | 341M YoY+1169.9% | -31.9M YoY+86.7% | -239M YoY-181.6% | |
| Interest paid | 37.7M YoY+11.5% | 33.8M YoY-17.6% | 41.0M YoY+1.7% | 40.3M YoY+32.1% | 30.5M YoY-5.9% | |
| Income taxes paid | 167M YoY-45.5% | 307M YoY+59.6% | 193M YoY-19.7% | 240M YoY+48.3% | 162M YoY+46.1% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 54.0B YoY+59.6% | 33.9B YoY-26.6% | 46.1B YoY+36.4% | 33.8B YoY-39.5% | 55.8B YoY+30.9% | |
| P/E | 51.0× YoY+33.7% | 38.1× YoY-31.9% | 56.0× YoY+10.4% | 50.7× YoY-32.3% | 75.0× YoY+2.3% | |
| P/S | 12.6× YoY+44.5% | 8.7× YoY-32.4% | 12.8× YoY+26.3% | 10.2× YoY-41.4% | 17.4× YoY+10.2% | |
| P/B | 33.7× YoY+58.6% | 21.2× YoY-40.2% | 35.5× YoY-50.2% | 71.4× YoY-11.8% | 80.9× YoY+20.0% | |
| P/FCF | 51.1× YoY+22.0% | 41.9× YoY-38.2% | 67.8× YoY-10.6% | 75.8× YoY-13.7% | 87.8× YoY+11.4% | |
| Earnings yield | 2.0% YoY-25.2% | 2.6% YoY+46.9% | 1.8% YoY-9.4% | 2.0% YoY+47.8% | 1.3% YoY-2.2% | |
| FCF yield | 2.0% YoY-18.0% | 2.4% YoY+61.8% | 1.5% YoY+11.8% | 1.3% YoY+15.8% | 1.1% YoY-10.2% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: IDXX's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all IDXX filings on SEC EDGAR → Not investment advice.
